- Home
- Publications
- Publication Search
- Publication Details
Title
Aggressive pituitary tumours and pituitary carcinomas
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-07
DOI
10.1038/s41574-021-00550-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas—A German Survey
- (2020) Ulf Elbelt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metastatic spread to the Pituitary
- (2020) Ilan Shimon NEUROENDOCRINOLOGY
- Pituitary-Tumor Endocrinopathies
- (2020) Shlomo Melmed NEW ENGLAND JOURNAL OF MEDICINE
- Radiation techniques in aggressive pituitary tumours and carcinomas
- (2020) Frederic Castinetti REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior
- (2020) T. M. Vicchio et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
- (2020) Jacqueline Trouillas et al. Cancers
- A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours ( PitNET )s
- (2020) Federica Guaraldi et al. CLINICAL ENDOCRINOLOGY
- Novel insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms
- (2020) Vinaya Srirangam Nadhamuni et al. ENDOCRINE REVIEWS
- Transcranial approach in giant pituitary adenomas: results and outcome in a modern series
- (2020) Thomas Graillon et al. Journal of Neurosurgical Sciences
- Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature
- (2020) Laura Lizzul et al. Pituitary
- The epidemiology of aggressive pituitary tumors (and its challenges)
- (2020) Olaf M. Dekkers et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Somatic SF3B1 hotspot mutation in prolactinomas
- (2020) Chuzhong Li et al. Nature Communications
- Gonadotroph Tumors Show Subtype Differences that Might Have Implications for Therapy
- (2020) Mirela Diana Ilie et al. Cancers
- Somatostatin receptor profile in pituitary thyrotroph adenomas
- (2020) Eleni Thodou et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- The tumour microenvironment of pituitary neuroendocrine tumours
- (2020) Pedro Marques et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Immune Landscape of Pituitary Neuroendocrine Tumours Reveals Association between Macrophages and Gonadotroph-Tumour Invasion
- (2020) Moitza Principe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment options for gonadotroph tumors: current state and perspectives
- (2020) Mirela Diana ILIE et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness
- (2020) Zihao Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sarcomas of the sellar region: a systematic review
- (2020) Fernando Guerrero-Pérez et al. Pituitary
- Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions
- (2020) Jacqueline Trouillas et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Somatostatin receptor expression and patients’ response to targeted medical treatment in pituitary tumors: evidences and controversies
- (2020) F. Gatto et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature
- (2020) Camille Duhamel et al. Journal of Personalized Medicine
- Aggressive Pituitary Adenomas and Carcinomas
- (2020) Mirela Diana Ilie et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: a new emerging treatment?
- (2020) Bastiaan Sol et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor
- (2020) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy
- (2020) Lydia S. Lamb et al. Frontiers in Endocrinology
- Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
- (2020) Nazanin Majd et al. Journal for ImmunoTherapy of Cancer
- Apatinib (YN968D1) and temozolomide in recurrent invasive pituitary adenoma: case report and literature review
- (2019) Yong Wang et al. World Neurosurgery
- Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
- (2019) Garima Yagnik et al. Oncotarget
- An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors
- (2019) Omalkhaire M. Alshaikh et al. ENDOCRINE PATHOLOGY
- The Intersection between Tumor Angiogenesis and Immune Suppression
- (2019) Osama E. Rahma et al. CLINICAL CANCER RESEARCH
- Surgery, octreotide, temozolomide, bevacizumab, radiotherapy and pegvisomant treatment of an AIP mutation positive child
- (2019) Pinaki Dutta et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical, pathological and molecular factors of aggressiveness in lactotroph tumours
- (2019) Jacqueline Trouillas et al. NEUROENDOCRINOLOGY
- Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors
- (2019) Mizuto Sato et al. Journal of Clinical Medicine
- Treatment and long-term outcomes in pituitary carcinoma: a cohort study
- (2019) Fernando Santos-Pinheiro et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Immune checkpoint inhibitors: The linchpins of modern immunotherapy
- (2019) Breelyn A. Wilky IMMUNOLOGICAL REVIEWS
- Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification
- (2019) Marie Buchy et al. Pituitary
- Emerging and Novel Treatments for Pituitary Tumors
- (2019) Ilie et al. Journal of Clinical Medicine
- The next generation of peptide receptor radionuclide therapy
- (2019) Tessa Brabander et al. ENDOCRINE-RELATED CANCER
- How and when to use temozolomide to treat aggressive pituitary tumours
- (2019) Ben C Whitelaw ENDOCRINE-RELATED CANCER
- Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease
- (2019) Hanna R Kemeny et al. CLINICAL CANCER RESEARCH
- An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy
- (2019) Majid Assadi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Outcomes of patients with Nelson’s syndrome after primary treatment: a multicenter study from 13 UK Pituitary centers
- (2019) Athanasios Fountas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aggressive prolactinomas: how to manage?
- (2019) Hélène Lasolle et al. Pituitary
- Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
- (2019) Pedro Marques et al. Acta Neuropathologica Communications
- The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
- (2019) Mirela Diana Ilie et al. Cancers
- Pangenomic Classification of Pituitary Neuroendocrine Tumors
- (2019) Mario Neou et al. CANCER CELL
- Lower 68 Ga‐DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland—A proof‐of‐concept study
- (2019) Axel Tjörnstrand et al. CLINICAL ENDOCRINOLOGY
- Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness
- (2019) Pedro Marques et al. ENDOCRINE-RELATED CANCER
- Definition and diagnosis of aggressive pituitary tumors
- (2019) Leandro Kasuki et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Pituitary Adenomas and Invasiveness from Anatomo-Surgical, Radiological, and Histological Perspectives: A Systematic Literature Review
- (2019) Simona Serioli et al. Cancers
- The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes
- (2018) Matthew P. Salomon et al. CLINICAL CANCER RESEARCH
- Aggressive pituitary tumours and carcinomas: two sides of the same coin?
- (2018) Jacqueline Trouillas et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas
- (2018) Mirella Hage et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
- (2018) Peng-fei Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Advances in studies of tyrosine kinase inhibitors and their acquired resistance
- (2018) Qinlian Jiao et al. Molecular Cancer
- Regression of a nonfunctioning pituitary macroadenoma on the CDK4/6 inhibitor palbociclib: case report
- (2018) Emily Anderson et al. Neurosurgical Focus
- Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review
- (2018) Frederick Yoo et al. Pituitary
- Surgical Outcomes Following Repeat Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas: A Retrospective Comparative Study
- (2018) Joshua Bakhsheshian et al. Operative Neurosurgery
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas
- (2018) Yohei Miyake et al. JOURNAL OF NEURO-ONCOLOGY
- New Developments in Peptide Receptor Radionuclide Therapy
- (2018) Guillaume P Nicolas et al. JOURNAL OF NUCLEAR MEDICINE
- Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study
- (2018) Amparo Wolf et al. LANCET ONCOLOGY
- High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
- (2018) Felix Behling et al. International Journal of Endocrinology
- Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre
- (2018) S Asioli et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- (2017) S L Asa et al. ENDOCRINE-RELATED CANCER
- Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients
- (2017) Julie Lelotte et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA
- (2017) Kristin Astrid Øystese et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
- (2017) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification
- (2017) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection
- (2017) Waseem Touma et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas
- (2017) Mark Gruppetta et al. Pituitary
- RIZ1 and histone methylation status in pituitary adenomas
- (2017) Yake Xue et al. TUMOR BIOLOGY
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- The genome-wide mutational landscape of pituitary adenomas
- (2016) Zhi-Jian Song et al. CELL RESEARCH
- Landscape of Genomic Alterations in Pituitary Adenomas
- (2016) Wenya Linda Bi et al. CLINICAL CANCER RESEARCH
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- Upregulation of Key Molecules for Targeted Imaging and Therapy
- (2016) V. F. Taelman et al. JOURNAL OF NUCLEAR MEDICINE
- Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary Tumors
- (2016) Marie Chanal et al. MOLECULAR CANCER THERAPEUTICS
- Is there a role for early chemotherapy in the management of pituitary adenomas?
- (2016) Andrew L. Lin et al. NEURO-ONCOLOGY
- Whole-exome sequencing identifies variants in invasive pituitary adenomas
- (2016) Xiaolei Lan et al. Oncology Letters
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
- (2015) Hua Gao et al. BMC CANCER
- Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas
- (2015) M. Lee et al. CLINICAL CANCER RESEARCH
- The Use of 68Ga DOTATATE PET/CT for Diagnostic Assessment and Monitoring of 177Lu DOTATATE Therapy in Pituitary Carcinoma
- (2015) Fuad Novruzov et al. CLINICAL NUCLEAR MEDICINE
- Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas
- (2015) Jian-Qiang Lu et al. ENDOCRINE PATHOLOGY
- Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)
- (2015) Joanne M. de Laat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2015) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification
- (2015) Alexander S. G. Micko et al. JOURNAL OF NEUROSURGERY
- The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
- (2014) Eric Monsalves et al. ENDOCRINE-RELATED CANCER
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Correlations of Pituitary Tumor Transforming Gene Expression with Human Pituitary Adenomas: A Meta-Analysis
- (2014) Jian-Qi Xiao et al. PLoS One
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- mTOR is Frequently Active in GH-Secreting Pituitary Adenomas without Influencing their Morphopathological Features
- (2013) Emir Ahmed Sajjad et al. ENDOCRINE PATHOLOGY
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas
- (2013) Jonathan Verma et al. Pituitary
- The Role of Epigenetic Modification in Tumorigenesis and Progression of Pituitary Adenomas: A Systematic Review of the Literature
- (2013) Matthew Pease et al. PLoS One
- Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment
- (2012) Melanie Philippon et al. ANNALES D ENDOCRINOLOGIE
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Pituitary Carcinoma with Malignant Growth from First Presentation and Fulminant Clinical Course—Case Report and Review of the Literature
- (2011) Katarzyna Dudziak et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas
- (2011) Lubin Qiu et al. Pituitary
- Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pituitary Tumors and Hyperplasia in Multiple Endocrine Neoplasia Type 1 Syndrome (MEN1): A Case-Control Study in a Series of 77 Patients Versus 2509 Non-MEN1 Patients
- (2009) Jacqueline Trouillas et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The pathophysiology of pituitary adenomas
- (2009) Dorota Dworakowska et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
- (2009) Alexander Gorshtein et al. ENDOCRINE-RELATED CANCER
- Predicting Recurrence of Nonfunctioning Pituitary Adenomas
- (2009) Tae-Woong Noh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor
- (2009) Marie S. Thearle et al. Pituitary
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
- (2008) Masami Ono et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started